Funder: Breakthrough T1D
Due Dates: June 10, 2025 (Letter of Intent) | July 17, 2025 (Full application)
Funding Amounts: Up to $900,000 total per project for up to 3 years; larger budgets/durations considered with strong justification.
Summary: Funds research to improve genetic risk assessment and prediction for type 1 diabetes across diverse populations, advancing risk scores for clinical screening and translation.
Key Information: Consortium participation is required for academic awardees; LOI is mandatory before full application.